Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
35.98
-0.30 (-0.83%)
At close: Jun 3, 2026, 4:00 PM EDT
35.40
-0.58 (-1.61%)
After-hours: Jun 3, 2026, 7:22 PM EDT
Legend Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 646.4 | 901.9 | 286.7 | 1,278 | 786.03 | 688.94 |
Short-Term Investments | 188.2 | 46.7 | 835.9 | 30.34 | 54.02 | 193.46 |
Trading Asset Securities | - | - | - | 0.66 | 185.6 | - |
Cash & Short-Term Investments | 834.6 | 948.6 | 1,123 | 1,309 | 1,026 | 882.4 |
Cash Growth | -16.99% | -15.50% | -14.22% | 27.60% | 16.23% | 74.49% |
Accounts Receivable | 1.7 | 13.1 | 6.4 | 101.43 | 0.28 | 50.5 |
Other Receivables | 184.9 | 237.2 | 118.7 | 55.63 | 44.24 | 8.04 |
Receivables | 186.6 | 250.3 | 125.1 | 157.06 | 44.52 | 58.55 |
Inventory | 37.1 | 32 | 23.9 | 19.43 | 10.35 | 1.75 |
Prepaid Expenses | 19.4 | 14.6 | 12.3 | 12.23 | 17.33 | 5.72 |
Other Current Assets | 5 | 1.6 | - | 0.36 | 1.27 | 1.44 |
Total Current Assets | 1,083 | 1,247 | 1,284 | 1,498 | 1,099 | 949.85 |
Property, Plant & Equipment | 452.5 | 401.5 | 201.2 | 189.23 | 160.76 | 140.79 |
Long-Term Investments | - | - | - | 4.36 | - | 4.71 |
Other Intangible Assets | - | - | - | 4.06 | 3.41 | 4.68 |
Long-Term Accounts Receivable | - | - | - | - | 0.4 | - |
Other Long-Term Assets | 61.5 | 85.1 | 185.1 | 153.16 | 67.28 | 19.44 |
Total Assets | 1,597 | 1,734 | 1,670 | 1,849 | 1,331 | 1,119 |
Accounts Payable | 74.3 | 83 | 38.6 | 30.66 | 32.89 | 7.04 |
Accrued Expenses | - | 123 | 64.5 | 61.58 | 152.73 | 104.38 |
Current Portion of Long-Term Debt | 266 | 319.1 | - | - | - | - |
Current Portion of Leases | 11.2 | 7.4 | 4.8 | 3.18 | 3.56 | 0.91 |
Current Income Taxes Payable | 20.3 | 19.2 | 20.7 | 7.2 | 9.77 | 9.49 |
Current Unearned Revenue | 6 | 11.3 | 47.4 | 53.08 | 0.45 | 0.3 |
Other Current Liabilities | 131.3 | 73.4 | 101.7 | 60.73 | 98.38 | 107.08 |
Total Current Liabilities | 509.1 | 636.4 | 277.7 | 216.42 | 297.79 | 229.2 |
Long-Term Debt | - | - | 301.2 | 281.33 | 260.93 | 120.46 |
Long-Term Leases | 112.1 | 87.2 | 44.6 | 44.17 | 20.04 | 1.59 |
Long-Term Unearned Revenue | - | - | 6.1 | 55.27 | 7.66 | 1.87 |
Other Long-Term Liabilities | 7.8 | 8 | - | 0.06 | 0.23 | 0.4 |
Total Liabilities | 629 | 731.6 | 629.6 | 597.24 | 586.65 | 353.52 |
Common Stock | 0.1 | 0.1 | 0.1 | 0.04 | 0.03 | 0.03 |
Additional Paid-In Capital | 2,781 | 2,750 | 2,696 | 2,637 | 1,657 | 1,261 |
Retained Earnings | -2,013 | -1,959 | -1,662 | -1,485 | -966.46 | -520.11 |
Comprehensive Income & Other | 199.5 | 210.2 | 6.2 | 98.93 | 53.72 | 24.57 |
Shareholders' Equity | 967.7 | 1,002 | 1,041 | 1,251 | 744.31 | 765.94 |
Total Liabilities & Equity | 1,597 | 1,734 | 1,670 | 1,849 | 1,331 | 1,119 |
Total Debt | 389.3 | 413.7 | 350.6 | 328.67 | 284.53 | 122.97 |
Net Cash (Debt) | 445.3 | 534.9 | 772 | 980.05 | 741.12 | 759.43 |
Net Cash Growth | -30.70% | -30.71% | -21.23% | 32.24% | -2.41% | 51.28% |
Net Cash Per Share | 2.41 | 2.90 | 4.22 | 5.57 | 4.66 | 5.39 |
Filing Date Shares Outstanding | 185.74 | 184.94 | 183.65 | 181.91 | 165.07 | 154.23 |
Total Common Shares Outstanding | 185.74 | 184.94 | 183.65 | 181.91 | 165.07 | 154.23 |
Working Capital | 573.6 | 610.7 | 1,006 | 1,281 | 801.33 | 720.65 |
Book Value Per Share | 5.21 | 5.42 | 5.67 | 6.88 | 4.51 | 4.97 |
Tangible Book Value | 967.7 | 1,002 | 1,041 | 1,247 | 740.9 | 761.26 |
Tangible Book Value Per Share | 5.21 | 5.42 | 5.67 | 6.86 | 4.49 | 4.94 |
Land | - | 2.9 | 2.9 | 2.89 | 2.89 | 2.89 |
Buildings | - | 66 | 65.5 | 65.54 | 45.08 | 16.01 |
Machinery | - | 57.5 | 45 | 45.48 | 46.26 | 38.27 |
Construction In Progress | - | 14.2 | 4.4 | 3.04 | 14.18 | 41.37 |
Leasehold Improvements | - | 22.6 | 21.3 | 23.12 | 21.97 | 20.91 |